Can Psychedelic-Derived Drugs Treat Depression Without Hallucinations?

Brightmindsbio08 Apr, 2026Finance

For decades, the resurgence of psychedelic research has reshaped how clinicians and neuroscientists think about mood disorders. Compounds once relegated to the margins are now being rigorously studied for their potential to treat depression—particularly treatment-resistant forms that fail to respond to conventional pharmacology. However, a central challenge remains: the very property that makes classical psychedelics therapeutically intriguing—their profound perceptual and cognitive effects—also limits scalability, regulatory acceptance, and patient accessibility.